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Thyroid-Hormone Metabolism in the Kidney* By VALERIE A. GALTON AND ROSALIND PITT-RIVERS National Institute for Medical Research, MiU Hill, London, N.W. 7 (Received 24 October 1958) Present knowledge of the metabolism of the thyroid hormones in the kidney is confined mainly to information obtained from experiments with 231I-labelled thyroxine and tri-iodothyronine. Gross & Leblond (1951 a) found that after the administration of ['31I] thyroxine to rats or mice, the kidney concentrated radioactivity from the blood. Subsequent chromatographic analysis of butanol extracts of kidney revealed the presence of at least four 'III-labelled compounds: thyroxine, tri-iodothyronine, iodide and an unknown compound which was later shown to give rise to thyroxine on alkaline hydrolysis (Leblond & Cambron, 1952) .
The compound was also detected in bile and was thought to be a conjugate of thyroxine with glucuronic acid. Gross, Ford, Symchowiez & Horton (1957) found that [UlI] tri-iodothyronine when aministered to rabbits gave rise to a metaboite in the kidney, plasma and liver which yielded triiodothyronine on hydrolysis with 0-2N-hydrochloric acid. The liver also contained a second conjugated compound which they identified as tri-iodothyronine glucuronide. Roche, Michel, Jouan & Wolf (1956) have shown that the kidney can deiodinate and deaminate [13I] tri-iodothyronine, forming 3:3'-di-iodothyronine and triiodothyroacetic acid [4-(4-hydroxy-3-iodophenoxy with large doses of 131J for thyroid carcinoma, and he suggested that they may be breakdown products of the thyroglobulin which was present in the serum of these patients. The maximum total '31I in the kidneys after tracer doses of 1311 is such that it is impossible to detect and identify satisfactorily the iodinated compounds present in a butanol extract of the tissue. However, by absorption on Dowex-1 it is possible to separate and concentrate the iodinated compounds from a sufficient amount of tissue to permit their detection by chromatographic analysis (Galton & Pitt-Rivers, 1959 ). The present work describes how this resin was used in a qualitative and quantitative study of thyroid-hormone metabolism in the kidneys of mice given very small doses of 1311.
METHODS AND MATERIALS
Preparation of tissue for analysis. Six male albino mice (20 g.) fed on diet 41 of Bruce & Parkes (1946) were used in each experiment. Each mouse received 1311 (10-20!c) intraperitoneally and was killed 60-72 hr. later by exsanguination under ether anaesthesia. Urine was taken from the bladders with a syringe. The kidneys were removed, rapidly skinned and weighed, rinsed in ice-cold 0 9 % NaCl soln. and homogenized in a pestle and mortar with thiouracil (2 mg.), 0.9 % NaCl soln. (6 ml.) and a little acid-washed sand. Homogenization was carried out slowly with the mortar standing in an ice-salt freezing mixture.
The homogenate was transferred to centrifuge tubes, a further 14 ml. of 0-9 % NaCl soln. was added and the mixture was shaken and centrifuged, the temperature being kept below 5B. The volume of the extract in 0.9% NaCl solution was measured and a portion was estimated for radioactivity in a well-type scintillation counter.
Column analys8i. The experiments were carried out at 4°. Dowex-I was equilibrated with sodium acetate buffer at pH 5-6. Sodium metabisulphite (0-02 mg./ml.) was added to all the eluents to prevent any oxidation of iodide on the column. The kidney extract was passed through the column (3 cm., 1 cm. diameter) of resin four times. The column was then washed with buffer at pH 5-6 until the eluate contained no detectable amount of protein, followed by buffer at pH 3-6, acetic acid solutions at pH 3-0, 2-2 and 1.4, undiluted acetic acid and finally 3N-NaBr. At least 10 ml. of each solution was passed through the column. The eluates were collected into 10 ml. graduated centrifuge tubes and samples were estimated for radioactivity. The resin itself was counted in the scintillation counter in order to be sure that all the radioactivity had been discharged.
Column analysis of the urine and serum was carried out in a similar manner.
Chromaographic analy8i8. A sample of urine was chromatographically analysed. The eluates containing radioactivity were pooled, evaporated to dryness under reduced pressure and the remaining acetic acid was removed in a stream of air. The residues were dissolved in methanol-aq. NH3 soln. (sp.gr. 0.88) (3:1) and analysed by paper chromatography as described by Galton & PittRivers (1959) . The solvent systems used were butan-l-oldioxan-aq. 2u-NH, soln. (4:1:5); butan-1-ol-2N-acetic acid (1:1); tert.-amyl alcohol-aq. 2x-NH3 soln. (1:1). Carriers were used for identification and stained by the method of Gross & Leblond (1951 b) . The chromatograms were scanned with a strip counter or radioautographed on X-ray film.
Identification of the, unknown metabolite Preparation of compound. In order to increase the specific activity of the metabolite the mice used in these experiments were given 200 ,uc of 131I. The kidneys from six mice were analysed on the column as previously described. The fraction eluted with 50% acetic acid (pH 1-4) was evaporated to dryness as previously described and the residue was dissolved in 0.1 ml. of methanol-aq. NH, soln.
This solution was chromatographed on paper in butanoldioxan-aq. NH3 soln. The area containing the metabolite was located with an end-window Geiger-Muller tube, removed and cut into pieces.
Hydrolysis of metabolite. The paper containing the metabolite was placed in a counting tube and 0-3 ml. of the acid, alkali or buffer solution to be used was added. The paper was removed from the liquid after 1 min., squeezed well with forceps and lifted out of the tube. The 1311 in the tube was estimated in the scintillation counter before and after the paper had been removed to check that satisfactory elution had been achieved; it was invariably found that 90-95% of the total ""1I on the paper was eluted by this technique. Attempts to hydrolyse the compound were made with 2N-HCI at 100°for 18 hr., 5N-HCl at 1000 for 1 hr. (SO2 was bubbled through the 5N-HCl during hydrolysis to prevent oxidative destruction) and N-NaOH at 1000 for 1 hr.
A crude preparation of ,-glucuronidase was made by suspending scrapings of the mucosa of the large intestine of a rat in a few drops of 0 9 % NaCl soln. Incubation of the metabolite was carried out in 01M-sodium phosphate buffer at pH 6-0, with 1 drop of this suspension, at 370 for 1, 4 or 18 hr.
Three arylsulphatases, free from ,B-glucuronidase, were incubated with the metabolite at 370 for 4 or 24 hr. These were a bacterial sulphatase from Alcaligenes metalcaligene8, in 0-1M-2-amino-2-hydroxymethylpropane-1:3-diol-HOC buffer at pH 9 0, a limpet sulphatase in 0.2m sodium acetate buffer at pH 5-5 and a rat-liver sulphatase in 0-1 msodium phosphate buffer at pH 8-0. The 13II-labelled compounds present in the incubation media or in the acid and alkali solutions were determined by chromatographic analysis.
Experiments with 35S-labelled sulphate
The metabolite was prepared from the kidneys of six mice injected with "3S-labelled sulphate in addition to 200,uc of 181I; carrier-free Na35SO4 (250,uc in 0-5 ml. of 0-9 % NaCl soln.) was injected twice subcutaneously into each mouse, 24 and 16 hr. before they were killed. The metabolite, purified by chromatography, was re-chromatographed in butanol-dioxan-aq. NH, soln. and the chromatogram was counted twice with a strip counter; the first time the end window was uncovered and the second time it was shielded with aluminium foil (11-4 mg./cm.2). This shield will absorb all the 35S radiation but alows about 60% of the 131I radiation to pass through (J. R. Tata, personal communication). For comparative purposes this technique was carried out on a chromatogram containing only a single radioactive spot of 131J. The proportion of radioactivity absorbed by the aluminium was determined by measuring the area under the peaks on the two records obtained from each chromatogram with a planimeter. The metabolite in this experiment was hydrolysed with the intestinal ,-glucuronidase and the products of hydrolysis were analysed by chromatography to determine whether 35S-labelled sulphate was released.
RESULTS
The 0-9 % NaCl soln. extract (19.4 ml.) from six kidneys (2.77 g.) contained at least 98% of the total 131I. It was evident from the column analysis of the kidney extract (Table 1 ) that thyroglobulin, mono-or di-iodotyrosine, which would have been discharged from the resin by acetate buffer at pH 3-6 and acetic acid solutions at pH 3-0 and 2-2, were not present. Two iodinated compounds, one of which was identified as thyroxine, were detected by chromatographic analysis of the fraction eluted with 50 % acetic acid (pH 1-4) ( Figs. 1 and 2) . Most of the 131I in this fraction (80-95 %) was in the form of a metabolite which could not be identified with any synthetic thyroxine analogue available. On some of the radioautographs a trace of radioactivity corresponding to tri-iodothyronine was detected. The amount of organically bound 131I present varied between 26 and 70 % of the total 131I in the kidney solution. The highest value was always obtained in the mice killed between 60 and 72 hr. after the injection of 131I.
The efficiency of the resin in absorbing the radioactivity from the saline solution was considerably less than that observed when only thyroxine and iodide were present (Galton & Pitt-Rivers, 1959) . In order to determine the nature of the unabsorbed 13I-labelled compounds, six mice were each given 200 ,c of 131I. They were killed 72 hr. later and the kidneys were analysed on the column. The protein solution was passed through the column four times and the radioactivity which remained in the solution was investigated by butanol extraction followed by chromatographic analysis. It was found that practically all the 131I was in the form of the unidentified metabolite described above (Fig. 2) ; only a trace amount of radioactivity corresponding to thyroxine was detected and this was of doubtful significance. In this experiment V0l. 7:2 Tert.-amyl alcohol-aq. 2N-NH, soln. the concentration of radioactivity in the fraction eluted with NaBr was high enough to permit chromatographic analysis; the 131I was entirely in the form of inorganic iodide. Column analysis of serum was also carried out (Table 2) . No radioactivity was detected in the fraction eluted with buffer at pH 3-6. This indicates that thyroglobulin was not present in the serum. Chromatographic analysis of the radioactive material eluted with 50 % acetic acid revealed that only thyroxine was present; there was no evidence that the unidentified metabolite present in kidney occurred in serum (Fig. 2) .
All detectable radioactive material in the urine was absorbed by the resin and could be eluted only with NaBr. Chromatographic analysis of a sample of urine confirmed that all the radioactivity The ratio organic L31I/inorganic 131I was 2-3 in the kidney and 1-8 in the serum. These values were calculated from column analyses of serum and tissues from the same group of mice (Tables 1  and 2 ). In another experiment the total 181I concentration in the kidneys and serum was about equal. The radioactivity in the urine was about 100 times 316 I959 THYROID-HORMONE METABOLISM IN THE KIDNEY Identification of unnknown metabolite 2N-Hydrochloric acid had little or no hydrolytic effect on the metabolite even at 1000 for 18 hr. However, with 5N-HC1 the metabolite was hydrolysed completely in 1 hr. When the hydrolysate was analysed by chromatography, only thyroxine was detected. The metabolite was also hydrolysed with N-NaOH but some deiodination of the liberated thyroxine also occurred. Hydrolysis of the metabolite was achieved within 1 hr. by the crude intestinal-enzyme preparation, but the three sulphatases had no effect on the compound; no thyroxine was detected in the media even after incubation for 24 hr.
From the control chromatogram it was estimated that the aluminium shield covering the end window of the strip counter absorbed 40 % of the 31I radiation. When a chromatogram containing the metabolite prepared from mice which had received 1""I and 85SO42-was scanned with and without this filter, only 40 % of the total radiation was absorbed, indicating that the metabolite contained no significant amount of sulphur. This conclusion was confirmed in the hydrolysis experiment. When the hydrolysate was chromatographically analysed, only one radioactive spot which corresponded to carrier thyroxine was detected; there was no evidence of any free radioactive sulphate.
DISCUSSION
The experiments described above indicate that at least 98 % of the total iodine present in the kidney is distributed among three substances: iodide, thyroxine and a third compound not previously identified in this organ. Tri-iodothyronine was occasionally found, but only in very small amounts. Although 60-70 % of the total iodine in the kidney is organically bound only 5-10 % of this is in the form of free thyroxine; at least half of the kidney iodine is in the form of the unknown metabolite. These estimations are subject to error owing to the presence ofurine in the kidney tubules; it is possible that the ratio of organic to inorganic iodine in the kidney cells is higher than was estimated here.
It was concluded that these results reflect the normal metabolism of iodine in the kidney because, first, the dose of 1311 used was small and radiation damage to the thyroid was not likely. The results obtained from the analysis of serum supported this view; no thyroglobulin was detected. Secondly, it was observed that the ratio of organic to inorganic 131I in the kidney did not reach a maximum until between 50 and 65 hr. after administration of 131I; after this interval the ratio remained approximately constant. This was taken as an indication that equilibration between the 131LI and 127I in the kidney had been reached. Thirdly, the technique permits a quantitative analysis of at least 98 % of the total 131I present in the kidney; in the kidney tissue the amount of radioactive material which was insoluble in sodium chloride solution was small and the resin showed no detectable radioactivity after the iodide had been eluted with sodium bromide solution.
The possibility that the metabolite was an artifact produced during the analytical procedure was eliminated as it was not found in serum or urine which were subjected to the same procedure. Further, the metabolite was detected in the kidneys of mice treated with larger doses of l31I which were not analysed on the column but were extracted with butanol.
On hydrolysis the metabolite yielded thyroxine. It was rapidly hydrolysed when incubated with scrapings of the mucosa of rat large intestine which contains both ,-glucuronidase and sulphatases
